医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Irish-Based Novaerus and Vinamedical Perform Signing Ceremony in Hanoi, Vietnam

2016年11月15日 AM02:14
このエントリーをはてなブックマークに追加


 

DUBLIN

Today, Novaerus and their local strategic partner Vinamedical recognized the introduction of Irish-based Novaerus technology in Vietnam with a signing ceremony at the Presidential Palace in Hanoi. The signing ceremony was witnessed by President of Ireland, Michael D. Higgins and President of Vietnam, Tran Dai Quang, during President Higgins’ State Visit to Vietnam. The Minister for Foreign Affairs and Trade, Charles Flanagan TD, was also in attendance at the ceremonial exchange which was organised by the Embassy of Ireland in Hanoi and Enterprise Ireland.

This event reflects the ongoing commitment both leaders have made to global market expansion and economic growth. The availability of the Novaerus technology in the Vietnamese market is an example of this type of growth.

In partnership with Vinamedical, a leading company in medical equipment supply in the Vietnam market, Novaerus’ airborne pathogen control technology will now be available throughout Vietnam. Anh Tuan Trinh, C.E.O. of Vinamedical remarks, “We really appreciate participating in this event.” He continues, “This marks not only another significant step in our global economic development, but also our ongoing commitment to provide cutting-edge medical technology in Vietnam and especially our focus in enhancing infection control for the benefit of the citizens.”

Novaerus provides a comprehensive infection defense system for indoor facilities. Strong enough to destroy bacteria, viruses, mold, spores and allergens. Its safe design runs 24/7 to annihilate airborne pathogens. Novaerus technology can be found in healthcare, education, hospitality and other commercial institutions across the globe.

“As a growing, innovative Irish-based company, we produce cutting-edge technology in the area of airborne infection control,” says Kieran McBrien, SVP of Sales, Europe and Asia. “This technology is making a significant difference in the global healthcare market. I am honored and inspired by the level of recognition and commitment that we’ve seen here today from both President Quang and President Higgins.” He adds, “I am also grateful to Enterprise Ireland, the Irish government overseas commercial support network. Their unstinting and creative support around the world has helped Novaerus enter 35 markets in the last 2 years.”

The signing ceremony will be followed by further economic development discussions. For more details about the visit click here.

About Novaerus

Novaerus is committed to the highest indoor air quality. Developed in 2008, Novaerus technology generates what is called a Dielectric Barrier Discharge plasma or DBD. When microorganisms in the air, including toxins, come into contact with the DBD plasma, they are eliminated. Novaerus technology is available in over 30 countries.

To learn more about Novaerus and its air quality control solutions, visit www.novaerus.com.

About Vinamedical

Vinamedical is a leading company in the medical equipment supply sector. The Vietnamese joint stock company provides healthcare specialists and individuals with the most innovative and effective solutions for healthcare technology. Working across all of Vietnam and Indochina, Vinamedical represents many large world medical brands in the market.

To learn more about Vinamedical, visit its official page at URL: http://vinamedical.vn/

View source version on businesswire.com: http://www.businesswire.com/news/home/20161114006205/en/

CONTACT

Novaerus
Media Contact
KJ Jones, 773-796-5825
Senior
Director of Marketing, Novaerus
kjones@novaerus.com
or
Vinamedical
Media
contact

Khuat Hong Hanh, (84) 4 3222 826
Marketing &
communication manager
honghanhkhuat@vinamedical.vn

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease